Inventor · Redwood City, CA, US

John E. Knox

20Patents
4h-index
59Co-inventors
58Inventor score

Filing activity: Jun 2, 2015 → Sep 27, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US10703733B2 MCL-1 inhibitors Human Necessities 10 Active
US10988451B2 MCL-1 inhibitors Human Necessities 9 Active
US11690915B2 Ras inhibitors Chemistry; Metallurgy 7 Active
US11739074B2 Ras inhibitors Chemistry; Metallurgy 7 Active
US11168102B1 Bicyclic heteroaryl compounds and uses thereof Chemistry; Metallurgy 4 Active
US10072001B2 Tank-binding kinase inhibitor compounds Chemistry; Metallurgy 3 Active
US10040781B2 Tank-binding kinase inhibitor compounds Chemistry; Metallurgy 3 Active
US11643400B2 MCL-1 inhibitors Human Necessities 3 Active
US12202845B2 Ras inhibitors Chemistry; Metallurgy 2 Active
US12252497B2 Ras inhibitors Chemistry; Metallurgy 2 Active
US11130759B1 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors Chemistry; Metallurgy 0 Active
US12162844B2 MCL-1 inhibitors Human Necessities 0 Active
US10253019B2 Tank-binding kinase inhibitor compounds Chemistry; Metallurgy 0 Active
US12168002B2 Heterocyclic carboxylate compounds as glycolate oxidase inhibitors Chemistry; Metallurgy 0 Active
US10316049B2 Tank-binding kinase inhibitor compounds Emerging Cross-Sectional Technologies 0 Active
US11046691B1 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors Chemistry; Metallurgy 0 Active
US10259811B2 Tank-binding kinase inhibitor compounds Chemistry; Metallurgy 0 Active
US11806335B2 Heterocyclic carboxylate compounds as glycolate oxidase inhibitors Chemistry; Metallurgy 0 Active
US12258366B2 Bicyclic heteroaryl compounds and uses thereof Chemistry; Metallurgy 0 Active
US11084798B1 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.